Strategic Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,251
| Closed | -$1.15M | – | 184 |
|
|
2025
Q1 | $1.15M | Sell |
10,251
-949
| -8% | -$97.9K | 0.22% | 91 |
|
|
2024
Q4 | $1.03M | Buy |
11,200
+500
| +5% | +$45K | 0.19% | 96 |
|
|
2024
Q3 | $897K | Hold |
10,700
| – | – | 0.17% | 111 |
|
|
2024
Q2 | $734K | Hold |
10,700
| – | – | 0.14% | 118 |
|
|
2024
Q1 | $784K | Sell |
10,700
-37
| -0.3% | -$2.85K | 0.15% | 113 |
|
|
2023
Q4 | $870K | Buy |
10,737
+37
| +0.3% | +$2.88K | 0.16% | 112 |
|
|
2023
Q3 | $802K | Hold |
10,700
| – | – | 0.16% | 115 |
|
|
2023
Q2 | $825K | Hold |
10,700
| – | – | 0.16% | 117 |
|
|
2023
Q1 | $888K | Hold |
10,700
| – | – | 0.18% | 110 |
|
|
2022
Q4 | $919K | Buy |
+10,700
| New | +$847K | 0.2% | 99 |
|
|
2021
Q1 | – | Sell |
-3,431
| Closed | -$214K | – | 166 |
|
|
2020
Q4 | $214K | Sell |
3,431
-2,669
| -44% | -$161K | 0.06% | 145 |
|
|
2020
Q3 | $387K | Sell |
6,100
-700
| -10% | -$48.5K | 0.13% | 112 |
|
|
2020
Q2 | $518K | Buy |
6,800
+3,000
| +79% | +$230K | 0.19% | 91 |
|
|
2020
Q1 | $285K | Hold |
3,800
| – | – | 0.12% | 122 |
|
|
2019
Q4 | $247K | Sell |
3,800
-300
| -7% | -$19.5K | 0.09% | 151 |
|
|
2019
Q3 | $260K | Sell |
4,100
-1,059
| -21% | -$69.2K | 0.1% | 147 |
|
|
2019
Q2 | $348K | Sell |
5,159
-1,770
| -26% | -$116K | 0.13% | 127 |
|
|
2019
Q1 | $450K | Sell |
6,929
-589
| -8% | -$39.1K | 0.17% | 106 |
|
|
2018
Q4 | $470K | Sell |
7,518
-2,991
| -28% | -$209K | 0.21% | 87 |
|
|
2018
Q3 | $811K | Sell |
10,509
-547
| -5% | -$41.3K | 0.3% | 72 |
|
|
2018
Q2 | $783K | Sell |
11,056
-284
| -3% | -$20.1K | 0.31% | 69 |
|
|
2018
Q1 | $855K | Sell |
11,340
-314
| -3% | -$25K | 0.35% | 66 |
|
|
2017
Q4 | $835K | Sell |
11,654
-1,592
| -12% | -$121K | 0.34% | 73 |
|
|
2017
Q3 | $1.07M | Buy |
13,246
+97
| +0.7% | +$7.42K | 0.47% | 61 |
|
|
2017
Q2 | $931K | Sell |
13,149
-2,184
| -14% | -$145K | 0.43% | 68 |
|
|
2017
Q1 | $1.04M | Buy |
+15,333
| New | +$1.08M | 0.49% | 64 |
|
|
2016
Q4 | – | Sell |
-12,267
| Closed | -$971K | – | 126 |
|
|
2016
Q3 | $971K | Sell |
12,267
-4,138
| -25% | -$336K | 0.54% | 64 |
|
|
2016
Q2 | $1.37M | Sell |
16,405
-452
| -3% | -$40.1K | 0.79% | 47 |
|
|
2016
Q1 | $1.55M | Buy |
16,857
+9,078
| +117% | +$819K | 0.88% | 38 |
|
|
2015
Q4 | $787K | Sell |
7,779
-376
| -5% | -$39.1K | 0.52% | 66 |
|
|
2015
Q3 | $801K | Buy |
8,155
+3,906
| +92% | +$434K | 0.56% | 63 |
|
|
2015
Q2 | $497K | Buy |
4,249
+1,831
| +76% | +$200K | 0.32% | 88 |
|
|
2015
Q1 | $200K | Sell |
2,418
-4,056
| -63% | -$412K | 0.13% | 131 |
|
|
2014
Q4 | $610K | Buy |
6,474
+3,043
| +89% | +$315K | 0.4% | 86 |
|
|
2014
Q3 | $365K | Buy |
3,431
+1,013
| +42% | +$99.2K | 0.24% | 102 |
|
|
2014
Q2 | $200K | Buy |
+2,418
| New | +$188K | 0.13% | 132 |
|
Other funds holding GILD
Strategic Advisors's GILD Position: Q2 2025 in Review
Strategic Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 10,251 shares — an estimated $1.15M sold.
Strategic Advisors first reported a position in GILD in Q2 2014 and held it in 36 quarters. The position peaked at $1.55M in Q1 2016. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- Strategic Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- Strategic Advisors sold 10,251 Gilead Sciences shares in Q2 2025, an estimated $1.15M.
- Strategic Advisors first reported a position in Gilead Sciences in Q2 2014 and held it in 36 quarters.
- Strategic Advisors's Gilead Sciences position peaked at $1.55M in Q1 2016.
- 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on Strategic Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.